Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,115B 11.73B 10.3B 9.48B 8.83B 16.66B 17B 114B 44.18B 547B 44.05B 43.09B 1,905B P/E 2027 *
25.6x
P/E 2028 * 21x
Enterprise Value 1,078B 11.34B 9.96B 9.17B 8.54B 16.11B 16.44B 110B 42.72B 529B 42.59B 41.67B 1,842B EV / Sales 2027 *
3.02x
EV / Sales 2028 * 2.68x
Free-Float
70.07%
Yield 2027 *
0.56%
Yield 2028 * 0.61%
1 day-3.45%
1 week-4.57%
Current month-3.45%
1 month+5.51%
3 months+3.86%
6 months-0.36%
Current year-0.36%
1 week 13.95
Extreme 13.95
15.67
1 month 12.96
Extreme 12.955
15.67
Current year 12.18
Extreme 12.185
15.67
1 year 12.18
Extreme 12.185
15.67
3 years 12.18
Extreme 12.185
16.89
5 years 9.58
Extreme 9.576
16.89
10 years 5.63
Extreme 5.626
16.89
Manager TitleAgeSince
Chief Executive Officer 59 2019-06-30
Director of Finance/CFO - 2024-07-31
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 2014-05-12
Chairman 65 2013-04-01
Director/Board Member 65 2018-10-24
Change 5-day change 1-year change 3-year change Capi.($)
-3.45%-4.57% - - 11.73B
-0.64%+6.67%+53.59%+154.11% 1,063B
+0.00%+5.39%+62.89%+53.44% 611B
-0.23%+6.88%+32.14%+86.34% 444B
+1.16%-0.96%+26.12%+20.22% 324B
+1.10%-0.40%+33.19%+22.86% 285B
+0.56%+0.53%+27.68%+38.89% 283B
-0.22%+4.00%-26.09%-41.06% 219B
-0.22%+2.82%+24.37%+62.75% 195B
-0.29%+0.65%+12.75%+63.45% 156B
Average -0.22%+2.83%+27.41%+51.22% 397.85B
Weighted average by Cap. -0.03%+4.16%+38.12%+75.97%

Financials

2027 *2028 *
Net sales 358B 3.76B 3.3B 3.04B 2.83B 5.34B 5.45B 36.57B 14.17B 176B 14.12B 13.82B 611B 395B 4.15B 3.64B 3.35B 3.13B 5.89B 6.01B 40.34B 15.63B 194B 15.58B 15.24B 674B
Net income 44.04B 463M 407M 374M 349M 658M 671M 4.5B 1.74B 21.62B 1.74B 1.7B 75.23B 54.03B 568M 499M 459M 428M 807M 823M 5.52B 2.14B 26.52B 2.13B 2.09B 92.3B
Net Debt -36.77B -387M -340M -313M -291M -549M -561M -3.76B -1.46B -18.05B -1.45B -1.42B -62.82B -59.17B -622M -546M -503M -469M -884M -902M -6.05B -2.34B -29.05B -2.34B -2.29B -101B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
26-07-01 US$13.99 -3.45% 3,552,180
26-06-30 US$14.49 -2.49% 3,387,385
26-06-29 US$14.86 -3.38% 5,316,971
26-06-26 US$15.38 +0.85% 3,693,979
26-06-25 US$15.25 +4.02% 4,615,233
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
39
Last Close Price
1,339.35INR
Average target price
1,337.93INR
Spread / Average Target
-0.11%

Quarterly revenue - Rate of surprise